Rock Creek Group’s Bristol-Myers Squibb BMY Stock Holding History

Rock Creek Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,636	Closed	-$153K	–	83
2023 Q3	$153K	Sell	2,636 -627	-19%	-$38.4K	0.02%	96
2023 Q2	$209K	Buy	3,263 +142	+5%	+$9.52K	0.03%	91
2023 Q1	$216K	Sell	3,121 -66	-2%	-$4.66K	0.03%	90
2022 Q4	$229K	Sell	3,187 -776	-20%	-$58.5K	0.03%	81
2022 Q3	$282K	Sell	3,963 -1,737	-30%	-$126K	0.04%	80
2022 Q2	$439K	Buy	5,700 +1,335	+31%	+$102K	0.05%	66
2022 Q1	$319K	Buy	4,365 +1,316	+43%	+$88.4K	0.04%	80
2021 Q4	$190K	Sell	3,049 -122	-4%	-$7.16K	0.03%	141
2021 Q3	$188K	Sell	3,171 -1,896	-37%	-$125K	0.03%	109
2021 Q2	$339K	Buy	5,067 +984	+24%	+$64.2K	0.05%	117
2021 Q1	$258K	Sell	4,083 -5,956	-59%	-$371K	0.04%	108
2020 Q4	$623K	Sell	10,039 -2,413	-19%	-$148K	0.26%	77
2020 Q3	$751K	Sell	12,452 -20,840	-63%	-$1.25M	0.39%	67
2020 Q2	$1.96M	Sell	33,292 -4,811	-13%	-$288K	1.04%	16
2020 Q1	$2.12M	Buy	38,103 +19,645	+106%	+$1.2M	1.17%	21
2019 Q4	$1.18M	Sell	18,458 -899	-5%	-$51.5K	0.47%	54
2019 Q3	$982K	Buy	19,357 +166	+0.9%	+$7.8K	0.47%	57
2019 Q2	$870K	Buy	19,191 +6,711	+54%	+$313K	0.4%	55
2019 Q1	$595K	Buy	+12,480	New	+$622K	0.27%	59

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Rock Creek Group's BMY Position: Q4 2023 in Review

Rock Creek Group sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 2,636 shares — an estimated $153K sold.

Rock Creek Group first reported a position in BMY in Q1 2019 and held it in 19 quarters. The position peaked at $2.12M in Q1 2020. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Rock Creek Group reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Rock Creek Group sold 2,636 Bristol-Myers Squibb shares in Q4 2023, an estimated $153K.
Rock Creek Group first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 19 quarters.
Rock Creek Group's Bristol-Myers Squibb position peaked at $2.12M in Q1 2020.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Rock Creek Group's 13F filing for Q4 2023, filed 13 Feb 2024.